A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer

Recruiting

Phase 1

BMS-986504 with Anticancer MedicationA Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer

Sponsor:

Memorial Sloan Kettering Cancer Center

Code:

NCT07532902

Conditions

Diffuse Pleural Mesothelioma

Gastroesophageal Carcinoma

Urothelial Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

BMS-986504

Ipilimumab

Nivolumab

5-FU

Leucovorin

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-05-14. This information was provided to ClinicalTrials.gov by Memorial Sloan Kettering Cancer Center on 2026-04-16.